Application 022058

Type
NDA
Sponsor
ENDO PHARM

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001SUPPRELIN LAHISTRELIN ACETATEIMPLANT;SUBCUTANEOUS50MGYesYes

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
67979-002SUPPRELINhistrelin acetateEndo Pharmaceuticals Inc.NDACurrent
67979-002SUPPRELINhistrelin acetateEndo Pharmaceuticals Solutions Inc.NDACurrent
67979-002SUPPRELINhistrelin acetateEndo Pharmaceuticals Inc.NDACurrent
67979-002SUPPRELINhistrelin acetateEndo Pharmaceuticals Inc.NDACurrent
67979-002SUPPRELINhistrelin acetateEndo Pharmaceuticals Inc.NDACurrent

Documents

DocumentSubmission typeDate
83462SUPPL 2025-09-25
83461SUPPL 2025-09-25
83425SUPPL 2025-09-24
70825SUPPL2022-04-27
70824SUPPL2022-04-27
70810SUPPL2022-04-26
60825SUPPL2019-11-13
60823SUPPL2019-11-12
60822SUPPL2019-11-12
48493SUPPL2017-05-23
48492SUPPL2017-05-23
48474SUPPL2017-05-22
48473SUPPL2017-05-22
48472SUPPL2017-05-22
48471SUPPL2017-05-19
38160SUPPL2016-07-13
38161SUPPL2013-04-09
6790SUPPL2013-04-03
16860SUPPL2012-04-06
6789SUPPL2012-04-06
16859SUPPL2011-11-18
29169SUPPL2011-11-02
24238ORIG2008-12-02
21922ORIG2008-12-02
38159SUPPL2008-07-09
29168SUPPL2008-07-08
29167SUPPL2007-11-26
6788ORIG2007-05-09
38158ORIG2007-05-07